Evaluating reliability of large language models for patient queries: Concordance with NCCN invasive breast cancer guideline using ChatGPT, DeepSeek, and Gemini.
Abstract
e12550 Background: The increasing use of large language models (LLMs) by patients seeking healthcare information emphasizes the need to evaluate their clinical reliability. Invasive breast cancer, characterized by nuanced, multi-stage treatment protocols, represents a key domain where LLM-generated patient guidance must be assessed against established clinical standards. Methods: We developed 62 patient-oriented questions based on NCCN guidelines for patients on invasive breast cancer, spanning eight clinical domains: general information, testing, staging, types of treatment, postoperative outcomes, supportive care, treatment options, and recurrence. Responses were generated by ChatGPT (GPT-5.2), DeepSeek (V3.2), and Gemini (2.5 Flash). Three board-certified oncologists evaluated each response across five metrics—factual accuracy, clarity, coherence, relevance, and completeness—using a 5-point Likert scale. Inter-rater reliability was assessed with a two-way random-effects intraclass correlation coefficient (ICC2). Differences between models were analyzed using Friedman’s chi-square test and Wilcoxon signed-rank post-hoc tests, with descriptive statistics computed per domain. Results: Inter-rater reliability was moderate for completeness (ICC = 0.39) and low for other metrics (ICC = 0.09–0.26). Across 186 responses (62 questions × 3 models), DeepSeek led in completeness (mean 4.65) and factual accuracy (4.26), Gemini in coherence (4.79) and relevance (4.56), and ChatGPT in clarity (4.84). Friedman tests showed significant differences in completeness (χ² = 42.05, p < 0.001) and clarity (χ² = 19.12, p < 0.001). Holm-adjusted Wilcoxon tests confirmed DeepSeek > ChatGPT in completeness (p < 0.001), Gemini > DeepSeek in coherence (p = 0.048), and ChatGPT > DeepSeek in clarity (p < 0.001). Clinical domain analyses revealed variability: DeepSeek excelled in completeness for supportive care (4.73/5, n = 15) and treatment options (4.50/5, n = 10), outperforming ChatGPT (3.53 & 3.60) and Gemini (4.60 & 4.10). Conversely, ChatGPT and Gemini were superior in clarity/coherence for informational domains—general information about invasive breast cancer (both 5.00 clarity, 5.00/4.86 coherence, n = 7 vs DeepSeek 3.71) and testing for breast cancer (both ~5.00/4.80–5.00, n = 5 vs DeepSeek 4.60). This pattern shows the need for domain-tuned LLMs in clinical patient guidance. Conclusions: The quality of LLM-generated patient information is highly domain-dependent, with each model exhibiting distinct strengths. Low inter-rater reliability emphasizes the challenge of consistent evaluation. While LLMs can serve as supplementary educational tools, their clinical integration requires careful, domain-specific validation and clear guidance regarding their variable performance across different topics in breast cancer care.
Article Details
Journal Info
Journal of Clinical Oncology
Lippincott Williams & Wilkins
Authors (14)
Amna Zaheer
Liaquat National Medical College, Karachi, Pakistan
Munazza Anwer
Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Mansi Kuntal
Government Medical College, Akola, India
Vidhi Ramesh Wadhwani
Gujarat Cancer Society (GCS) Medical College, Hospital and Research Centre, Ahmedabad, India
Uswah Imran Shaikh
Liaqauat National Hospital and Medical College, Karachi, Sindh, Pakistan
Jamuna Shrestha
Manipal College of Medical Sciences, Pokhara, Nepal
Gina J. Singh
University of Missouri-Kansas City, Mission Hills, KS
Vikas Gopalrao Dod
University of Texas, Dallas, TX
Deepti Bala Kallam
USMD Cancer Center, Dallas, TX
Zahra Ali
6Bolan Medical College, Quetta, Pakistan
Syed Mohsin Raza Bukhari
Nishtar Medical University, Multan, Pakistan
Ankita Gupta
Shajadi Patan
1University of Kansas Medical Center, Division of Hematologic Malignancies & Cellular Therapeutics, Kansas City, United States
Ahsun Rizwan Siddiqi
Henry Ford St. John Hospital, Detroit, MI